MedTrace Logo

Sequential bpMRI for Suspicious Prostate Lesions

NCT07332832 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-02-18

No results posted yet for this study

Summary

This study aims to establish a prospective exploratory cohort and database to observe the dynamic evolution of bi-parametric MRI (bpMRI). Investigators intend to study the clinical utility of sequential MRI combined with prostate biopsy in the diagnosis of prostate cancer. Specifically, by utilizing bpMRI findings and their dynamic changes to guide the timing of biopsies, investigators aim to avoid unnecessary procedures. Furthermore, the safety and efficacy of this strategy will be assessed through long-term follow-up, ultimately promoting the precision diagnosis and treatment of prostate cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

PSA test

Blood PSA test every 6 months

DIAGNOSTIC_TEST

Bi parametric MRI

Bi parametric MRI examination every year.

Sponsors & Collaborators

  • Shanghai East Hospital of Tongji University

    collaborator OTHER

  • Peking University First Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2028-12-31
Completion
2029-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07332832 on ClinicalTrials.gov